Literature DB >> 10514297

Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells.

E I Montero1, S Díaz, A M González-Vadillo, J M Pérez, C Alonso, C Navarro-Ranninger.   

Abstract

The synthesis and chemical characterization of three new transplatinum complexes of structural formula trans-[PtCl(2)(amine)(isopropylamine)] (amine = n,n-dimethylamine, propylamine, and butylamine), 1-3, are described. Cytotoxicity tests in tumor cell lines sensitive to cis-DDP (Jurkat, Hela, and Vero) and also in tumor cell lines overexpressing ras oncogenes and resistant to cis-DDP (HL-60 and Pam 212-ras) show that complexes 1 and 3 have higher cytotoxic activity than cisplatin. Moreover, these two trans-Pt(II) complexes kill Pam 212-ras cells through apoptosis induction. These results suggest that trans-PtCl(2) complexes with asymmetric aliphatic amines may be considered a new class of biologically active trans-platinum drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514297     DOI: 10.1021/jm991015e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides.

Authors:  Leticia Cubo; Ana M Pizarro; Adoración Gómez Quiroga; Luca Salassa; Carmen Navarro-Ranninger; Peter J Sadler
Journal:  J Inorg Biochem       Date:  2010-04-28       Impact factor: 4.155

2.  Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.

Authors:  Leticia Cubo; Michael Groessl; Paul J Dyson; Adoración G Quiroga; Carmen Navarro-Ranninger; Angela Casini
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

Review 3.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

4.  cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.

Authors:  Gabriel E Büchel; Susanne Kossatz; Ahmad Sadique; Peter Rapta; Michal Zalibera; Lukas Bucinsky; Stanislav Komorovsky; Joshua Telser; Jörg Eppinger; Thomas Reiner; Vladimir B Arion
Journal:  Dalton Trans       Date:  2017-09-12       Impact factor: 4.390

5.  Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes.

Authors:  Sheena M Aris; David A Gewirtz; John J Ryan; Kenneth M Knott; Nicholas P Farrell
Journal:  Biochem Pharmacol       Date:  2007-02-28       Impact factor: 5.858

6.  Solution behaviour and biological activity of bisamidine complexes of platinum(II).

Authors:  C Marzano; S Mazzega Sbovata; F Bettio; R A Michelin; R Seraglia; T Kiss; A Venzo; R Bertani
Journal:  J Biol Inorg Chem       Date:  2007-01-09       Impact factor: 3.862

7.  Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes.

Authors:  Marcelo Echeverri; Amparo Alvarez-Valdés; Francisco Navas; Josefina Perles; Isabel Sánchez-Pérez; A G Quiroga
Journal:  R Soc Open Sci       Date:  2018-02-21       Impact factor: 2.963

8.  Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.

Authors:  V Cepero; B García-Serrelde; V Moneo; F Blanco; A M González-Vadillo; A Alvarez-Valdés; C Navarro-Ranninger; A Carnero
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.340

9.  Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds?

Authors:  Eva Corral; Anna C G Hotze; Hans den Dulk; Anna Leczkowska; Alison Rodger; Michael J Hannon; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2008-12-16       Impact factor: 3.358

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.